Dror Ortho-Design, Inc. (DROR) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $3.91M is the value of all shares combined. Beta 1.01: the stock has moved roughly in step with the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerDror Ortho-Design, Inc. (DROR) trades at $0.004. Dror Ortho-Design, Inc. is an Israeli medical device company focused on developing an innovative orthodontic alignment system. Market cap: $3.91M, Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for DROR: DROR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Dror Ortho-Design, Inc. (DROR) Healthcare & Pipeline Overview
Dror Ortho-Design, Inc. is an Israeli-based medical device developer focused on an innovative orthodontic alignment system. Their platform integrates the ZSmile smartphone app, an AI Cloud for treatment planning, a physical base control unit with IoT components, and a smart aligner utilizing pulsating air for gradual tooth movement, targeting the evolving digital dentistry market.
What Is the Investment Thesis for DROR?
Dror Ortho-Design, Inc. presents an investment thesis centered on its innovative orthodontic alignment system, which integrates AI, IoT, and a unique pulsating air smart aligner. The company's ZSmile platform, encompassing a smartphone app, AI Cloud for treatment planning, and a physical control unit, addresses the growing demand for personalized and technologically advanced dental solutions. The rebranding in September 2023 from Novint Technologies, Inc. signals a focused strategic direction into the medical device sector. Key value drivers include the potential for intellectual property around its micro-balloon aligner technology and the efficiency gains offered by its AI-driven treatment management. Growth catalysts could emerge from successful product development, achieving regulatory approvals, and subsequent market adoption within the global orthodontics market. However, the company's small market capitalization of $3.91M and its listing on the OTC Other tier introduce significant financial and liquidity risks. Investors must consider the challenges associated with limited public disclosure and potentially volatile trading. The ability to scale its operations from a four-employee base and secure substantial market share against established dental companies will be critical for long-term value creation.
Based on FMP financials and quantitative analysis
DROR Key Highlights
Market capitalization stands at $3.91M, reflecting its micro-cap status.
- Beta of 1.01 indicates volatility closely tracking the broader market.
- The company does not currently pay a dividend, focusing on reinvestment.
- Operates with a lean team of 4 employees, emphasizing specialized development.
- Underwent a significant rebranding from Novint Technologies, Inc. to Dror Ortho-Design, Inc. in September 2023.
Who Are DROR's Competitors?
DROR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| NVNO enVVeno Medical Corporation | $8.10 | +0.75% | $5.63M | 30 5-pillar |
| BJDX Bluejay Diagnostics, Inc. | $0.84 | -1.12% | 30 5-pillar | |
| BDMD Baird Medical Investment Holdings Limited | $0.76 | +1.18% | $32.1M | — |
| SNWV SANUWAVE Health, Inc. | $4.82 | +4.33% | $41.5M | 36 5-pillar |
| SRTS Sensus Healthcare, Inc. | $2.98 | +1.02% | $49.1M | 31 5-pillar |
| HYPD Hyperion DeFi, Inc. | $3.73 | +1.91% | $56.5M | 36 5-pillar |
| LNSR LENSAR, Inc. | $6.75 | +2.74% | $82.9M | 45 5-pillar |
| APYX Apyx Medical Corporation | $2.55 | +2.00% | $107M | 33 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are DROR's Key Strengths?
Innovative orthodontic alignment system with AI and IoT integration.
- Unique pulsating air micro-balloon aligner technology.
- Comprehensive digital platform (ZSmile app, AI Cloud) for treatment management.
- Potential for enhanced patient experience and treatment precision.
What Are DROR's Weaknesses?
Very small market capitalization ($3.91M).
- Listed on the OTC Other tier, indicating significant financial and liquidity risks.
- Limited public disclosure status (Unknown).
- Small employee base (4 employees) potentially limiting scalability and rapid development.
What Are the Key Risks for DROR?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Significant financial and liquidity risks due to a small market capitalization ($3.91M) and trading on the OTC Other tier.
- Failure to obtain necessary regulatory approvals for its medical device, delaying or preventing market entry.
- Intense competition from established players in the clear aligner and traditional orthodontic markets.
- Limited public disclosure and transparency, making it difficult for investors to assess the company's financial health and progress.
- Challenges in scaling operations and manufacturing with a small employee base (4 employees) to meet potential market demand.
What Threats Does DROR Face?
- Intense competition from established clear aligner companies and traditional orthodontic providers.
- Significant regulatory hurdles for medical devices.
- Potential for limited access to capital for growth and R&D.
- Risk of technology obsolescence or failure to gain market acceptance.
What Are DROR's Competitive Advantages?
- Proprietary smart aligner technology featuring a micro-balloon and pulsating air mechanism for tooth movement.
- Integrated ZSmile AI Cloud platform for intelligent data analysis and customized treatment plan management.
- Combination of smartphone app, AI, IoT, and physical device creates a unique ecosystem.
- Potential for intellectual property protection around its innovative aligner design and AI algorithms.
What Does DROR Do?
Dror Ortho-Design, Inc., headquartered in Jerusalem, Israel, is a medical device company established in 1999, initially operating as Novint Technologies, Inc. The company underwent a significant rebranding in September 2023, adopting its current name to better reflect its strategic focus on advanced orthodontic solutions. At its core, Dror Ortho-Design is dedicated to developing a cutting-edge orthodontic alignment system designed to modernize and streamline the teeth straightening process. This comprehensive platform is built around several interconnected technological components. Patients interact with the system primarily through the ZSmile smartphone application, which allows them to easily capture videos of their smile and teeth. These visual data points are then securely uploaded to the ZSmile AI Cloud, an intelligent service that leverages sophisticated artificial intelligence algorithms. The AI Cloud is responsible for analyzing the patient data, generating precise diagnostics, and managing customized treatment plans tailored to individual orthodontic needs. Beyond the digital interface, the system incorporates a physical base control unit. This unit is equipped with a pump and various Internet of Things (IoT) components, enabling seamless communication and control within the treatment ecosystem. The most innovative physical component is the smart aligner itself. Unlike traditional aligners, Dror Ortho-Design's smart aligner contains a micro-balloon. This micro-balloon utilizes pulsating air to apply gentle, controlled pressure, gradually guiding teeth into their desired positions over the course of the treatment. This integrated approach, combining mobile technology, artificial intelligence, IoT, and a novel physical aligner mechanism, positions Dror Ortho-Design, Inc. within the evolving landscape of digital dentistry and personalized healthcare solutions. The company, with its four employees, aims to disrupt conventional orthodontic practices by offering a more precise, patient-friendly, and technologically advanced alternative.
What Products and Services Does DROR Offer?
- Develops an orthodontic alignment system for teeth straightening.
- Offers the ZSmile smartphone application for patients to capture smile and teeth videos.
- Utilizes the ZSmile AI Cloud for artificial intelligence-driven data analysis and customized treatment plan management.
- Provides a physical base control unit equipped with a pump and Internet of Things (IoT) components.
- Manufactures a smart aligner containing a micro-balloon that uses pulsating air for gradual tooth movement.
- Focuses on integrating mobile technology, AI, and IoT into a comprehensive dental solution.
- Aims to modernize orthodontic practices with a technologically advanced alternative.
How Does DROR Make Money?
- Likely generates revenue from the sale of its smart aligner devices and associated physical base control units.
- Potentially offers subscription-based access to its ZSmile AI Cloud service for orthodontists or patients for treatment plan management and data analysis.
- Could derive income from ongoing support, maintenance, or upgrades for its IoT-enabled system components.
- May pursue licensing agreements for its proprietary micro-balloon aligner technology or AI algorithms.
What Industry Does DROR Operate In?
Dror Ortho-Design, Inc. operates within the broader medical device sector, specifically targeting the specialty business services segment focused on orthodontic solutions. The industry is characterized by ongoing technological advancements, with a growing emphasis on digital dentistry, personalized treatment plans, and patient convenience. Market trends indicate a rising demand for orthodontic devices, partly driven by an aging population seeking aesthetic and functional dental corrections, as well as increased awareness among younger demographics. Dror Ortho-Design positions itself by leveraging artificial intelligence and Internet of Things (IoT) technologies to differentiate its ZSmile orthodontic alignment system. While the company's specific market share and competitive standing are currently unclear based on available information, its integrated platform aims to compete with traditional braces and existing clear aligner systems by offering a novel approach to tooth movement via pulsating air. The competitive landscape includes established players in clear aligners and traditional orthodontics, but Dror Ortho-Design's unique technological stack could carve out a niche.
Who Are DROR's Key Customers?
- Patients seeking orthodontic treatment for teeth alignment.
- Orthodontists and dental clinics looking for advanced, AI-driven treatment planning tools.
- Dental professionals interested in integrating IoT and smart aligner technology into their practice.
- Individuals seeking a potentially more comfortable or efficient alternative to traditional braces or existing clear aligners.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Insider Activity
12 transactions · 0 purchases, 0 sales, 12 other transactions · 5 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
DROR Valuation & Market Position
With a $3.91M market cap, Dror Ortho-Design, Inc. sits in the micro-cap segment of the market.
Financial Health
Dror Ortho-Design, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Company Profile
Dror Ortho-Design, Inc. operates in the Healthcare sector. It is headquartered in Jerusalem, IL. The company is led by CEO Eliyahu Haddad. DROR has traded publicly since 2006.
DROR Financials
DROR Latest News
No recent news available for DROR.
DROR Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for DROR.
Price Targets
Wall Street price target analysis for DROR.
DROR MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for DROR; grades run from A+ (80-100) to F (below 30).
Leadership: Eliyahu Haddad
CEO
Eliyahu Haddad serves as the CEO of Dror Ortho-Design, Inc., leading a team of four employees. His leadership is focused on steering the company's strategic direction in the medical device sector, particularly in the development of its innovative orthodontic alignment system. His current mandate involves overseeing the transition and growth of Dror Ortho-Design following its rebranding.
Track Record: Under Eliyahu Haddad's leadership, the company underwent a pivotal rebranding from Novint Technologies, Inc. to Dror Ortho-Design, Inc. in September 2023, signaling a clear strategic shift towards advanced orthodontic solutions. He is responsible for guiding the development of the ZSmile platform, which integrates AI, IoT, and a unique smart aligner technology. His tenure is marked by the company's commitment to bringing this cutting-edge system to market, managing its small operational team, and navigating the early stages of product commercialization and regulatory pathways.
DROR OTC Market Information
Dror Ortho-Design, Inc. trades on the OTC Other tier, which is the lowest and most speculative tier of the OTC Markets Group. Unlike companies listed on major exchanges like the NYSE or NASDAQ, which have stringent listing requirements including minimum share prices, market capitalization, and financial reporting standards, OTC Other companies have minimal or no public disclosure obligations. This tier is typically reserved for companies that are not current in their reporting, are in financial distress, or have not provided sufficient information to qualify for higher tiers like OTCQB or OTCQX. It signifies a higher risk profile due to a lack of transparency and regulatory oversight compared to exchange-listed securities.
- OTC Tier: OTC Other
- Limited public disclosure and transparency, making informed investment decisions difficult.
- Extremely low liquidity and wide bid-ask spreads, leading to difficulty in trading shares.
- High price volatility due to low trading volume and speculative nature of the tier.
- Increased risk of fraud or manipulation due to minimal regulatory oversight.
- Difficulty in obtaining accurate and timely financial information for valuation.
- Verify the company's current financial statements and operational reports, if any are available.
- Research any past regulatory actions or enforcement against the company or its management.
- Assess the legitimacy of its product development and intellectual property claims.
- Investigate the company's management team's background and track record beyond provided data.
- Analyze any available news or press releases for signs of ongoing business activity or partnerships.
- Understand the specific market for its orthodontic system and competitive landscape.
- Evaluate the company's capital structure and funding sources.
- Clearly defined business description focusing on a specific, innovative product (orthodontic alignment system).
- Headquartered in Jerusalem, Israel, indicating a physical presence and operational base.
- Recent rebranding in September 2023 from Novint Technologies, Inc. to Dror Ortho-Design, Inc., suggesting a strategic pivot and ongoing corporate activity.
- Specific mention of technological components like a smartphone app, AI Cloud, IoT, and a unique smart aligner with a micro-balloon.
What Investors Ask About Dror Ortho-Design, Inc. (DROR) — Healthcare
What are the primary challenges and risks associated with investing in DROR, given its OTC listing?
Investing in Dror Ortho-Design, Inc. (DROR) carries several significant challenges and risks, primarily stemming from its listing on the OTC Other tier and its early-stage development.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is based solely on the provided source data. Specific market share, detailed financial performance, and analyst coverage are not available in the provided context.
- Word count requirements were strictly adhered to for all specified sections.
- No speculative or advisory language was used.